Helperby Has Nearly 20 Years Experience Designing Combinations Of Antimicrobials In Order To Rejuvenate Old Drugs And To Find More Uses For Drugs That Already Exist On The Marketwe Have Developed Research Tools To Screen For And Quantify The Extent Of Synergy Occurring Between Different Combinations Of Old Drugsusing This Information We Can Identify Optimally Matched Combinations And Most Of Our Patented Combinations See 8 To 64 Fold Synergy In Bacterial Kill Counts In Vitrosynergistic Interactions Allow Us To Achieve Better Effects With Lower Doses And We Have A Phase Ii Trial Underway With Our Lead Product Zidistinimproves Dosing Regimen Of Colistimethate Combined With Azidothymidinemore Recently Helperby Therapeutics Has Initiated A Program Aimed At A Cure For The New Coronavirus
